TearLab Corporation has chosen Positive Impact as its commercial partner for the UK and Ireland markets.
Positive Impact will help TearLab with the promotion and market development of the TearLab Osmolarity System, which helps to diagnose and manage patients with dry eye disease.
Director of marketing and professional services for Positive Impact Nick Atkins said: ‘We look forward to this new partnership with TearLab and believe the company’s point-of-care technology will complement well our portfolio of products for management of the ocular surface. This technology dovetails perfectly with our growing portfolio of best-in-class dry eye diagnostic and treatment products.’
TearLab executive vice president Paul Smith added: ‘PI’s deep experience in clinical education make it an ideally suited partner to support and continue developing the UK and Ireland markets for both existing TearLab users and new clinicians alike.’